Programs & Pipelines

Pipeline

Programs Indications Preclinical IND Enabling Activities Phase 1 Phase 2 Global Rights
CB4211 NASH
Preclinical Phase complete
IND Enabling Activities Phase complete
Phase 1 Phase in progress
Phase 2 Phase not started
CohBar, Inc. logo
Obesity
Preclinical Phase complete
IND Enabling Activities Phase complete
Phase 1 Phase in progress
Phase 2 Phase not started
CohBar, Inc. logo
CB5138 Analogs IPF, Fibrotic Diseases
Preclinical Phase in progress
IND Enabling Activities Phase not started
Phase 1 Phase not started
Phase 2 Phase not started
CohBar, Inc. logo

CB4211 for Nonalcoholic Steatohepatitis (NASH) and Obesity

Novel Mechanism of Action: Enhances Insulin Signaling

The first analog from our technology platform to be tested in humans.

View Program

CB5138 Analogs for IPF and other Fibrotic Diseases

Anti-fibrotic & Anti-inflammatory

View Program

Posters & White Papers

View our posters and white papers regarding our research and science.

View Publications